trial · primary record
Quemliclustat
Metastatic Pancreatic Ductal Adenocarcinoma
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 610 |
| Primary completion | 2030-11-30 |
| Primary endpoint | Overall Survival (OS) |
| Registry ID | NCT06608927 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:09.343Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06608927
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.